Parameters | Reciprocal n = 29 | Non-reciprocal n = 14 [synergistic/irrelevant] | p value |
---|---|---|---|
Age | |||
 < 60 | 12 | 7 [3/4] | 0.5943 |
 ≥ 60 | 17 | 7 [2/5] | |
Gender | |||
 Male | 18 | 13 [5/8] | 0.0667 |
 Female | 11 | 1 [0/1] | |
Recurrence | |||
 New | 25 | 10 [3/7] | 0.4038 |
 Recurrent | 4 | 4 [2/2] | |
Tumor size | |||
 < 5 cm | 15 | 7 [2/5] | 0.9156 |
 ≥ 5 cm | 14 | 7 [3/4] | |
Tumor multiplicity | |||
 Single | 21 | 11 [4/7] | > 0.9999 |
 Multiple | 8 | 3 [1/2] | |
HBV | |||
 Positive | 16 | 6 [3/3] | 0.4490 |
 Negative | 13 | 8 [2/6] | |
HCV | |||
 Positive | 6 | 5 [2/3] | 0.2900 |
 Negative | 23 | 9 [3/6] | |
No HBV or HCV | |||
 Yes | 8 | 3 [0/3] | > 0.9999 |
 No | 21 | 11 [5/6] | |
Serum AFP | |||
 High ≥ 14 | 25 | 10 [5/5] | 0.4038 |
 Low < 14 | 4 | 4 [0/4] | |
Serum PIVKA-IIa | |||
 High ≥ 40 | 20 | 9 [4/5] | 0.6369 |
 Low < 40 | 8 | 5 [1/4] | |
Child–Pugh score | |||
 A | 26 | 11 [5/6] | 0.3728 |
 B | 3 | 3 [0/3] | |
Pre-operative therapy | |||
 Yes | 3 | 5 [2/3] | 0.0452 |
 No | 26 | 9 [3/6] | |
Cirrhosis | |||
 Yes | 17 | 3 [1/2] | 0.0275 |
 No | 12 | 11 [4/7] | |
Capsular invasion | |||
 Yes | 21 | 9 [2/7] | 0.5866 |
 No | 8 | 5 [3/2] | |
Vascular invasion | |||
 Yes | 21 | 9 [4/5] | 0.5866 |
 No | 8 | 5 [1/4] | |
Tumor differentiationb | |||
 Well | 3 | 1 [0/1] | 0.4239 |
 Moderate | 17 | 11 [4/7] | |
 Poor | 9 | 2 [1/1] | |
TNM stageb | |||
 I | 1 | 2 [0/2] | > 0.9999 |
 II | 7 | 1 [1/0] | |
 III | 12 | 8 [1/7] | |
 IV | 9 | 3 [3/0] |